Explore more publications!

Press Releases

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics
American Assets Trust, Inc. Reports Fourth Quarter and Year End 2025 Financial Results
U.S. Department of Justice Announces Compensation Process for Victims of Chinese Liberal Education Holdings Ltd. (CLEU) Investment Fraud Scheme

U.S. Department of Justice Announces Compensation Process for Victims of Chinese Liberal Education Holdings Ltd. (CLEU) Investment Fraud Scheme

Alamos Gold Announces Island Gold District Expansion to 20,000 TPD, Creating One of Canada’s Largest and Lowest Cost Gold Mines with Attractive Economics, including 69% After-Tax IRR and $12.2 Billion NPV at $4,500/oz Gold
Ring Energy Announces Sonu Johl Named New Chief Financial Officer
Overland AI Raises $100 Million to Scale Ground Autonomy with U.S. Armed Forces
AMD Reports Fourth Quarter and Full Year 2025 Financial Results
Telix Full Year Results 2025 Investor Webcast Notification
BRBR STOCK NEWS: BellRing Brands Stock Plummets and Additional 14% -- BFA Law Reminds Investors of its Pending Securities Fraud Class Action
Quarterly Report Investor Webinar

Quarterly Report Investor Webinar

Leslie’s, Inc. to Report First Quarter 2026 Financial Results on February 17, 2026
Enphase Energy Reports Financial Results for the Fourth Quarter of 2025
eGain Announces Second Quarter 2026 Financial Results
PennantPark Investment Corporation Announces Monthly Distribution of $0.08 per Share
Lloyd & Mousilli Expands U.S. Presence with New Location in Coral Gables
InnovAge Announces Financial Results for the Fiscal Second Quarter Ended December 31, 2025
Varonis Announces Fourth Quarter 2025 and Full-Year 2025 Financial Results
Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Corcept Therapeutics Incorporated – CORT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INO

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions